PPD, Inc. has entered into an exclusive agreement with Peking Union Lawke Biomedical Development Ltd. (PUL), expanding its global central lab services into China. The agreement allows PPD to start providing its full range of central lab services in China to biopharmaceutical clients.     “Chinese law makes it extremely difficult to export lab samples to other countries for testing,” said Agostino L. Fede, Ph.D., senior vice president of PPD and head of PPD’s global central l...